Molecular functions and therapeutic applications of exosomal noncoding RNAs in cancer

참고문헌 (163)

1. Hanahan, D., "The hallmarks of cancer", Cell, 100, pp.57~70 (2000)
2. Hanahan, D., "Hallmarks of cancer : the next generation", Cell, 144, pp.646~674 (2011)
3. Cocozza, F., "SnapShot:extracellular vesicles", Cell, 182, pp.262~262.e261 (2020)
4. Greening, D. W., "Emerging roles of exosomes during epithelial-mesenchymal transition and cancer progression", Semin. Cell Dev. Biol, 40, pp.60~71 (2015)
5. Valadi, H., "Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells", Nat. Cell Biol, 9, pp.654~659 (2007)
6. Théry, C., "Exosomes: secreted vesicles and intercellular communications", F1000Biol. Rep, 3, pp.15~ (2011)
7. Iero, M., "Tumour-released exosomes and their implications in cancer immunity", Cell Death Differ, 15, pp.80~88 (2008)
8. Lee, Y. J., "Multiplex bioimaging of piRNA molecular pathway-regulated theragnostic effects in a single breast cancer cell using a piRNA molecular beacon", Biomaterials, 101, pp.143~155 (2016)
9. Zhao, Y. M., "HIWI is associated with prognosis in patients with hepatocellular carcinoma after curative resection", Cancer, 118, pp.2708~2717 (2012)
10. Théry, C., "Minimal information for studies of extracellular vesicles 2018(MISEV2018) : a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines", J. Extracell. Vesicles, 7, pp.1535750~1535750 (2018)
11. Théry, C., "Exosomes : composition, biogenesis and function", Nat. Rev. Immunol, 2, pp.569~579 (2002)
12. Trams, E. G., "Exfoliation of membrane ectoenzymes in the form of micro-vesicles", Biochim. Biophys. Acta, 645, pp.63~70 (1981)
13. Harding, C., "Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes", J. Cell Biol, 97, pp.329~339 (1983)
14. Johnstone, R. M., "Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes)", J. Biol. Chem, 262, pp.9412~9420 (1987)
15. Cabral, J., "Extracellular vesicles as modulators of wound healing", Adv. Drug Deliv. Rev, 129, pp.394~406 (2018)
16. Lindenbergh, M. F. S., "Antigen presentation by extracellular vesicles from professional antigen-presenting cells", Annu. Rev. Immunol, 36, pp.435~459 (2018)
17. Becker, A., "Extracellular vesicles in cancer : cell-to-cell mediators of metastasis", Cancer Cell, 30, pp.836~848 (2016)
18. György, B., "Membrane vesicles, current state-of-the-art : emerging role of extracellular vesicles", Cell. Mol. Life Sci, 68, pp.2667~2688 (2011)
19. de Gassart, A., "Exosome secretion: the art of reutilizing nonrecycled proteins?", Traffic, 5, pp.896~903 (2004)
20. Kharaziha, P., "Tumor cell-derived exosomes : a message in a bottle", Biochim. Biophys. Acta, 1826, pp.103~111 (2012)
21. Cai, Z., "Activated T cell exosomes promote tumor invasion via Fas signaling pathway", J. Immunol, 188, pp.5954~5961 (2012)
22. Azmi, A. S., "Exosomes in cancer development, metastasis, and drug resistance : a comprehensive review", Cancer Metastasis Rev, 32, pp.623~642 (2013)
23. Huang, X., "Characterization of human plasma-derived exosomal RNAs by deep sequencing", BMC Genomics, 14, pp.319~ (2013)
24. Cheng, L., "Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine", Kidney Int, 86, pp.433~444 (2014)
25. Liu, T., "Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer", Oncotarget, 7, pp.85551~85563 (2016)
26. Lim, L. P., "Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs", Nature, 433, pp.769~773 (2005)
27. Calin, G. A., "A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia", N. Engl. J. Med, 353, pp.1793~1801 (2005)
28. Umezu, T., "Leukemia cell to endothelial cell communication via exosomal miRNAs", Oncogene, 32, pp.2747~2755 (2013)
29. Zhang, Y., "Secreted monocytic miR-150 enhances targeted endothelial cell migration", Mol. Cell, 39, pp.133~144 (2010)
30. Tkach, M., "Communication by extracellular vesicles : where we are and where we need to go", Cell, 164, pp.1226~1232 (2016)
31. Rupaimoole, R., "MicroRNA therapeutics : towards a new era for the management of cancer and other diseases", Nat. Rev. Drug Discov, 16, pp.203~222 (2017)
32. Xu, W. W., "Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression", Nat. Commun, 8, pp.14399~ (2017)
33. Li, B., "MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF", Oncogene, 36, pp.3986~4000 (2017)
34. Chiam, K., "Circulating serum exosomal miRNAs As potential biomarkers for esophageal adenocarcinoma", J. Gastrointest. Surg, 19, pp.1208~1215 (2015)
35. Kogure, T., "Intercellular nanovesiclemediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth", Hepatology, 54, pp.1237~1248 (2011)
36. Grimolizzi, F., "Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression", Sci. Rep, 7, pp.15277~ (2017)
37. Monaco, F., "Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma : Role of miR-126 in cancer-stroma communication", Cancer Lett, 463, pp.27~36 (2019)
38. Wang, L., "Exosomal release of microRNA-454 by breast cancer cells sustains biological properties of cancer stem cells via the PRRT2", Wnt axis in ovarian cancer, 2020, pp.257, 118024~
39. Melo, S. A., "Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis", Cancer Cell, 26, pp.707~721 (2014)
40. Fang, T., "Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer", Nat. Commun, 9, pp.191~ (2018)
41. Zhou, W., "Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis", Cancer Cell, 25, pp.501~515 (2014)
42. Fong, M. Y., "Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis", Nat. Cell Biol, 17, pp.183~194 (2015)
43. Matsumura, T., "Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer", Br. J. Cancer, 113, pp.275~281 (2015)
44. Bryant, R. J., "Changes in circulating microRNA levels associated with prostate cancer", Br. J. Cancer, 106, pp.768~774 (2012)
45. Li, Z., "Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients", Onco Targets Ther, 9, pp.139~148 (2016)
46. Nishida, N., "Angiogenesis in cancer", Vasc. Health Risk Manag, 2, pp.213~219 (2006)
47. Zhuang, G., "Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway", EMBO J, 31, pp.3513~3523 (2012)
48. Cui, H., "Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes", Oncogene, 34, pp.3640~3650 (2015)
49. Kosaka, N., "Neutral sphingomyelinase 2(nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis", J. Biol. Chem, 288, pp.10849~10859 (2013)
50. Liu, Y., "STAT3-regulated exosomal miR-21 promotes angiogenesis and is involved in neoplastic processes of transformed human bronchial epithelial cells", Cancer Lett, 370, pp.125~135 (2016)
51. Wu, X. G., "Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma", Angiogenesis, 22, pp.397~410 (2019)
52. Zheng, H. C., "The molecular mechanisms of chemoresistance in cancers", Oncotarget, 8, pp.59950~59964 (2017)
53. Eichelser, C., "Increased serum levels of circulating exosomal microRNA-373in receptor-negative breast cancer patients", Oncotarget, 5, pp.9650~9663 (2014)
54. Challagundla, K. B., "Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy", J. Natl. Cancer Inst, 107, pp.7~ (2015)
55. Sasako, M., "Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer", J. Clin. Oncol, 29, pp.4387~4393 (2011)
56. Sakuramoto, S., "Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine", N. Engl. J. Med, 357, pp.1810~1820 (2007)
57. Tsuburaya, A., "Sequential paclitaxel followed by tegafur and uracil(UFT)or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a", b gastric cancer(SAMIT) : a phase 3 factorial randomised controlled trial, 2014, pp.15, 886~893
58. Jin, G., "A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer", Cancer Chemother. Pharmacol, 84, pp.315~325 (2019)
59. Li, B., "Identification of miR-29c and its Target FBXO31 as a key regulatory mechanism in esophageal cancer chemoresistance : functional validation and clinical significance", Theranostics, 9, pp.1599~1613 (2019)
60. Zhou, Y., "Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancerassociated fibroblasts", J. Exp. Clin. Cancer Res, 37, pp.324~ (2018)
61. Olejarz, W., "Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers", Int. J. Mol. Sci, 21, pp.16~ (2020)
62. Bartel, D. P., "MicroRNAs : genomics, biogenesis, mechanism, and function", Cell, 116, pp.281~297 (2004)
63. Ørom, U. A., "MicroRNA-10a binds the 5’UTR of ribosomal protein mRNAs and enhances their translation", Mol. Cell, 30, pp.460~471 (2008)
64. Kulkarni, B., "Exosomal miRNA in chemoresistance, immune evasion, metastasis and progression of cancer", Drug Discov. Today, 24, pp.2058~2067 (2019)
65. Zhao, S., "Tumor-derived exosomal miR-934 induces macrophage M2polarization to promote liver metastasis of colorectal cancer", J. Hematol. Oncol, 13, pp.156~ (2020)
66. Zhang, X., "Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT", Mol. Cancer, 18, pp.40~ (2019)
67. Lin, Q., "Exosome-mediated miRNA delivery promotes liver cancer EMT and metastasis", Am. J. Transl. Res, 12, pp.1080~1095 (2020)
68. Mori, M. A., "Extracellular miRNAs : from biomarkers to mediators of physiology and disease", Cell Metab, 30, pp.656~673 (2019)
69. Yan, W., "Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells", Nat. Cell Biol, 20, pp.597~609 (2018)
70. Zheng, P., "Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells", J. Exp. Clin. Cancer Res, 36, pp.53~ (2017)
71. Lu, J., "Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK", AKT pathway in nasopharyngeal carcinoma, 2018, pp.37, 147~
72. Huang, S., "The emerging role of circular RNAs in transcriptome regulation", Genomics, 109, pp.401~407 (2017)
73. Salmena, L., "A ceRNA hypothesis : the Rosetta Stone of a hidden RNA language?", Cell, 146, pp.353~358 (2011)
74. Hansen, T. B., "Natural RNA circles function as efficient microRNA sponges", Nature, 495, pp.384~388 (2013)
75. Memczak, S., "Circular RNAs are a large class of animal RNAs with regulatory potency", Nature, 495, pp.333~338 (2013)
76. Fanale, D., "Circular RNA in exosomes", Adv. Exp. Med. Biol, 1087, pp.109~117 (2018)
77. Li, Y., "A novel circFMN2 promotes tumor proliferation in CRC by regulating the miR-1182", hTERT signaling pathways, 2019, pp.133, 2463~2479
78. Feng, W., "circIFT80 Functions as a ceRNA of miR-1236-3p to Promote Colorectal Cancer Progression", Mol. Ther. Nucleic Acids, 18, pp.375~387 (2019)
79. Zhang, H., "Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7", Oncogene, 38, pp.2844~2859 (2019)
80. Li, Y., "Circular RNA is enriched and stable in exosomes : a promising biomarker for cancer diagnosis", Cell Res, 25, pp.981~984 (2015)
81. Zhang, X., "Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1", mTOR pathway, 2019, pp.18, 20~
82. Xie, M., "Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p", HUR, Mol. Cancer, pp.2020, 19[DOI]
83. Conn, S. J., "The RNA binding protein quaking regulates formation of circRNAs", Cell, 160, pp.1125~1134 (2015)
84. Wang, J., "Exosome-transmitted long non-coding RNA SENP3-EIF4A1 suppresses the progression of hepatocellular carcinoma", Aging, 12, pp.11550~11567 (2020)
85. Li, L., "FLI1 exonic circular rnas as a novel oncogenic driver to promote tumor metastasis in small cell lung cancer", Clin. Cancer Res, 25, pp.1302~1317 (2019)
86. Xu, L., "The circular RNA ciRS-7(Cdr1as)acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma", J. Cancer Res. Clin. Oncol, 143, pp.17~27 (2017)
87. Yang, H., "Hypoxia induced exosomal circRNA promotes metastasis of Colorectal Cancer via targeting GEF-H1", RhoA axis, 2020, pp.10, 8211~8226
88. Huang, X. Y., "Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis", J. Exp. Clin. Cancer Res, 39, pp.20~ (2020)
89. Geng, X., "Circular RNA : biogenesis, degradation, functions and potential roles in mediating resistance to anticarcinogens", Epigenomics, 12, pp.267~283 (2020)
90. Ding, C., "Exosome-mediated transfer of circRNA CircNFIX enhances temozolomide resistance in glioma", Cancer Lett, 479, pp.1~12 (2020)
91. Wang, X., "Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer", Mol. Oncol, 14, pp.539~555 (2020)
92. Hon, K. W., "Extracellular Vesicle-derived circular RNAs confers chemoresistance in colorectal cancer", Sci. Rep, 9, pp.16497~ (2019)
93. Zhang, P. F., "Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma", Mol. Cancer, 19, pp.110~ (2020)
94. Li, Z., "Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338", MACC1, Cancer Lett, pp.2018, 432[DOI]
95. Li, J., "Circular RNA IARS(circ-IARS)secreted by pancreatic cancer cells and located within exosomes regulates endothelial monolayer permeability to promote tumor metastasis", J. Exp. Clin. Cancer Res, 37, pp.177~ (2018)
96. Dai, X., "Exosomal circRNA_100284 from arsenite-transformed cells, via microRNA-217 regulation of EZH2, is involved in the malignant transformation of human hepatic cells by accelerating the cell cycle and promoting cell proliferation", Cell Death Dis, 9, pp.454~ (2018)
97. Chen, W., "Exosome-transmitted circular RNA hsa_circ_0051443 suppresses hepatocellular carcinoma progression", Cancer Lett, 475, pp.119~128 (2020)
98. Wang, G., "Three isoforms of exosomal circPTGR1 promote hepatocellular carcinoma metastasis via the miR449a-MET pathway", EBioMedicine, 40, pp.432~445 (2019)
99. Wang, S., "Circ-0000284 arouses malignant phenotype of cholangiocarcinoma cells and regulates the biological functions of peripheral cells through cellular communication", Clin. Sci, 133, pp.1935~1953 (2019)
100. Zong, Z. H., "CircWHSC1 promotes ovarian cancer progression by regulating MUC1 and hTERT through sponging miR-145and miR-1182", J. Exp. Clin. Cancer Res, 38, pp.437~ (2019)
101. Wang, R., "CircNT5E acts as a sponge of miR-422a to promote glioblastoma tumorigenesis", Cancer Res, 78, pp.4812~4825 (2018)
102. Tian, L., "CircRASSF2 promotes laryngeal squamous cell carcinoma progression by regulating the miR-302b-3p", IGF-1R axis, 2019, pp.133, 1053~1066
103. Dou, Y., "Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes", Sci. Rep, 6, pp.37982~ (2016)
104. Moran, V. A., "Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs", Nucleic Acids Res, 40, pp.6391~6400 (2012)
105. Rinn, J. L., "Genome regulation by long noncoding RNAs", Annu. Rev. Biochem, 81, pp.145~166 (2012)
106. Zhang, Y., "Exosome-Transmitted lncRNA H19 Inhibits the Growth of Pituitary Adenoma", J. Clin. Endocrinol. Metab, 104, pp.6345~6356 (2019)
107. Yang, X., "The long non-coding RNA PCSEAT exhibits an oncogenic property in prostate cancer and functions as a competing endogenous RNA that associates with EZH2", Biochem. Biophys. Res. Commun, 502, pp.262~268 (2018)
108. Liang, Y., "LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303", PTBP3 axis, 2020, pp.19, 85~
109. Zang, X., "Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression", Cell Death Dis, 11, pp.215~ (2020)
110. Li, B., "Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis", Oncogene, 37, pp.5508~5519 (2018)
111. Xue, M., "Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1", Mol. Cancer, 16, pp.143~ (2017)
112. Jin, N., "Long non-coding RNA TIRY promotes tumor metastasis by enhancing epithelial-to-mesenchymal transition in oral cancer", Exp. Biol. Med, 245, pp.585~596 (2020)
113. Zhang, Q., "Exosomes transferring long non-coding RNA FAL1 to regulate ovarian cancer metastasis through the PTEN", AKT signaling pathway, 2020, pp.24, 43~54
114. Zhang, R., "Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer", Biochem. Biophys. Res. Commun, 490, pp.406~414 (2017)
115. Zheng, R., "Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression", Mol. Cancer, 17, pp.143~ (2018)
116. Hardin, H., "Thyroid cancer stem-like cell exosomes : regulation of EMT via transfer of lncRNAs", Lab. Investig, 98, pp.1133~1142 (2018)
117. Wu, D. M., "TGF-β-mediated exosomal lnc-MMP2-2 regulates migration and invasion of lung cancer cells to the vasculature by promoting MMP2 expression", Cancer Med, 7, pp.5118~5129 (2018)
118. Gao, T., "Exosomal lncRNA 91H is associated with poor development in colorectal cancer by modifying HNRNPK expression", Cancer Cell Int, 18, pp.11~ (2018)
119. Liang, Z. X., "LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2polarization", Cell Death Dis, 10, pp.829~ (2019)
120. Meseure, D., "Long noncoding RNAs as new architects in cancer epigenetics, prognostic biomarkers, and potential therapeutic targets", Biomed. Res. Int, 2015, pp.320214~ (2015)
121. Conigliaro, A., "CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA", Mol. Cancer, 14, pp.155~ (2015)
122. Herbert, S. P., "Molecular control of endothelial cell behaviour during blood vessel morphogenesis", Nat. Rev. Mol. Cell Biol, 12, pp.551~564 (2011)
123. Zhao, Y., "Targeting angiogenesis in cancer therapy : moving beyond vascular endothelial growth factor", Oncologist, 20, pp.660~673 (2015)
124. Lang, H. L., "Glioma cells promote angiogenesis through the release of exosomes containing long non-coding RNA POU3F3", Eur. Rev. Med. Pharmacol. Sci, 21, pp.959~972 (2017)
125. Lang, H. L., "Glioma cells enhance angiogenesis and inhibit endothelial cell apoptosis through the release of exosomes that contain long non-coding RNA CCAT2", Oncol. Rep, 38, pp.785~798 (2017)
126. Cheng, Y., "Low long noncoding RNA growth arrest-specific transcript 5expression in the exosomes of lung cancer cells promotes tumor angiogenesis", J. Oncol, 2019, pp.2476175~ (2019)
127. Wang, X., "Exosome-mediated transfer of long noncoding RNA H19 induces doxorubicin resistance in breast cancer", J. Cell. Physiol, 235, pp.6896~6904 (2020)
128. Dong, H., "Exosome-mediated transfer of lncRNA‑SNHG14 promotes trastuzumab chemoresistance in breast cancer", Int. J. Oncol, 53, pp.1013~1026 (2018)
129. Xu, C. G., "Exosomes mediated transfer of lncRNA UCA1 results in increased tamoxifen resistance in breast cancer cells", Eur. Rev. Med. Pharmacol. Sci, 20, pp.4362~4368 (2016)
130. Wang, J., "Exosome-mediated transfer of lncRNA HOTTIP promotes cisplatin resistance in gastric cancer cells by regulating HMGA1", miR-218 axis, 2019, pp.12, 11325~11338
131. Zhang, W., "Exosome-mediated transfer of lncRNA RP11‑838N2.4 promotes erlotinib resistance in non-small cell lung cancer", Int. J. Oncol, 53, pp.527~538 (2018)
132. Kang, M., "Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA", J. Exp. Clin. Cancer Res, 37, pp.171~ (2018)
133. Qu, L., "Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA", Cancer Cell, 29, pp.653~668 (2016)
134. Takahashi, K., "Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy", Mol. Cancer Res, 12, pp.1377~1387 (2014)
135. Takahashi, K., "Extracellular vesiclemediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer", FEBS Open Bio, 4, pp.458~467 (2014)
136. Luo, X., "Exosomal lncRNA HNF1A-AS1 affects cisplatin resistance in cervical cancer cells through regulating microRNA-34b", TUFT1 axis, 2019, pp.19, 323~
137. Dvinge, H., "RNA components of the spliceosome regulate tissue-and cancer-specific alternative splicing", Genome Res, 29, pp.1591~1604 (2019)
138. Dvinge, H., "RNA splicing factors as oncoproteins and tumour suppressors", Nat. Rev. Cancer, 16, pp.413~430 (2016)
139. Liu, Y., "Tumor exosomal RNAs promote lung pre-metastatic niche formation by activating alveolar epithelial TLR3 to recruit neutrophils", Cancer Cell, 30, pp.243~256 (2016)
140. Dong, X., "Small nuclear RNAs(U1, U2, U5)in tumor-educated platelets are downregulated and act as promising biomarkers in lung cancer", Front. Oncol, 10, pp.1627~1627 (2020)
141. Scott, M. S., "From snoRNA to miRNA: dual function regulatory noncoding RNAs", Biochimie, 93, pp.1987~1992 (2011)
142. Liao, J., "Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer", Mol. Cancer, 9, pp.198~ (2010)
143. Morse, M. A., "A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer", J. Transl. Med, 3, pp.9~ (2005)
144. Merchant, M. L., "Isolation and characterization of urinary extracellular vesicles : implications for biomarker discovery", Nat. Rev. Nephrol, 13, pp.731~749 (2017)
145. Zhou, Q., "Immune-related microRNAs are abundant in breast milk exosomes", Int. J. Biol. Sci, 8, pp.118~123 (2012)
146. Peng, P., "Exosomes in the ascites of ovarian cancer patients : origin and effects on anti-tumor immunity", Oncol. Rep, 25, pp.749~762 (2011)
147. Li, M., "Analysis of the RNA content of the exosomes derived from blood serum and urine and its potential as biomarkers", Philos. Trans. R. Soc. Lond. B Biol. Sci, 369, pp.1652~ (2014)
148. Taylor, D. D., "MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer", Gynecol. Oncol, 110, pp.13~21 (2008)
149. Cazzoli, R., "microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer", J. Thorac. Oncol, 8, pp.1156~1162 (2013)
150. Huang, X., "Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer", Eur. Urol, 67, pp.33~41 (2015)
151. Munagala, R., "Exosomal miRNAs as biomarkers of recurrent lung cancer", Tumour Biol, 37, pp.10703~10714 (2016)
152. Lee, Y. R., "Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma", Int. J. Cancer, 144, pp.1444~1452 (2019)
153. Tsukamoto, M., "Circulating exosomal MicroRNA-21 as a biomarker in each tumor stage of colorectal cancer", Oncology, 92, pp.360~370 (2017)
154. Xu, H., "Serum exosomal long noncoding RNAs ENSG00000258332.1 and LINC00635 for the diagnosis and prognosis of hepatocellular carcinoma", Cancer Epidemiol. Biomark. Prev, 27, pp.710~716 (2018)
155. Xu, H., "Identification of serum exosomal lncRNA MIAT as a novel diagnostic and prognostic biomarker for gastric cancer", J. Clin. Lab. Anal, 34, pp.e23323~ (2020)
156. Chen, X., "PRMT5 circular RNA promotes metastasis of urothelial carcinoma of the bladder through sponging miR-30c to induce epithelial-mesenchymal transition", Clin. Cancer Res, 24, pp.6319~6330 (2018)
157. Wu, G., "Circular RNA profiling reveals exosomal circ_0006156 as a novel biomarker in papillary thyroid cancer", Mol. Ther. Nucleic Acids, 19, pp.1134~1144 (2020)
158. Tao, X., "Clinical significance of hsa_circ_0000419 in gastric cancer screening and prognosis estimation", Pathol. Res. Pract, 216, pp.152763~ (2020)
159. Shao, Y., "Hsa_circ_0065149 is an indicator for early gastric cancer screening and prognosis prediction", Pathol. Oncol. Res, 26, pp.1475~1482 (2020)
160. Tang, W., "CircRNA microarray profiling identifies a novel circulating biomarker for detection of gastric cancer", Mol. Cancer, 17, pp.137~ (2018)
161. Liang, J., "Sphk2 RNAi nanoparticles suppress tumor growth via downregulating cancer cell derived exosomal microRNA", J. Control. Release, 286, pp.348~357 (2018)
162. Li, H., "Exosomes derived from siRNA against GRP78modified bone-marrow-derived mesenchymal stem cells suppress Sorafenib resistance in hepatocellular carcinoma", J. Nanobiotechnology, 16, pp.103~ (2018)
163. Wang, C., "Exosome-delivered TRPP2 siRNA inhibits the epithelialmesenchymal transition of FaDu cells", Oncol. Lett, 17, pp.1953~1961 (2019)

관련 논문AI추천